Zonisamide and Bronchitis - a phase IV clinical study of FDA data

Summary:

Bronchitis is reported as a side effect among people who take Zonisamide (zonisamide), especially for people who are male, 0-1 old, have been taking the drug for < 1 month also take Valproate Sodium, and have Infantile spasms.

The phase IV clinical study analyzes which people have Bronchitis when taking Zonisamide. It is created by eHealthMe based on reports of 11,045 people who have side effects when taking Zonisamide from the FDA, and is updated regularly.

What is Zonisamide?

Zonisamide has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 11,445 Zonisamide users. Check the latest studies of Zonisamide.

What is Bronchitis?

Bronchitis (inflammation of the mucous membrane in the bronchial tubes) is found to be associated with 2,329 drugs and 2,440 conditions by eHealthMe. Check the latest studies of Bronchitis.

On Jul, 14, 2026

11,045 people reported to have side effects when taking Zonisamide.
Among them, 43 people (0.39%) have Bronchitis.

Among these 43 people:

How long have people been on Zonisamide when they have Bronchitis? *

What is the gender of people who have Bronchitis when taking Zonisamide? *

female: 43.9 %
male: 56.1 %

What is the age of people who have Bronchitis when taking Zonisamide? *

What are other drugs people take besides Zonisamide? *

What are other side effects people have besides Bronchitis? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 10 people, 23.26%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 8 people, 18.60%
Gastroenteritis (inflammation of stomach and intestine): 8 people, 18.60%
Dyspnea (difficult or laboured breathing): 7 people, 16.28%
Dehydration (dryness resulting from the removal of water): 6 people, 13.95%
Upper Respiratory Tract Inflammation: 6 people, 13.95%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 13.95%
Chest Pain: 6 people, 13.95%
Pneumonia: 5 people, 11.63%
Drug Ineffective: 5 people, 11.63%

What are the existing conditions these people have? *

Infantile Spasms: 13 people, 30.23%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 9.30%
Bipolar Disorder (mood disorder): 2 people, 4.65%
Partial Seizures (seizures which affect only a part of the brain at onset): 2 people, 4.65%
Immunodeficiency Common Variable: 2 people, 4.65%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 4.65%
Micturition Urgency (urgency to pass the urine): 1 person, 2.33%
Cystic Fibrosis (disease of the secretary glands): 1 person, 2.33%
Diabetes: 1 person, 2.33%
High Blood Cholesterol: 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zonisamide and have Bronchitis?

- Check whether Bronchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zonisamide:

Zonisamide (11,445 reports)

Bronchitis treatments and more:

Bronchitis (118,921 reports)

Browse all side effects of Zonisamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchitis:

Bronchitis (2,329 drugs)

Browse all the conditions that are associated with Bronchitis:

Bronchitis (2,440 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zonisamide (the active ingredients of Zonisamide) and Zonisamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.